Warning: mkdir(): No space left on device in /www/wwwroot/zhenghe1718.com/func.php on line 127

Warning: file_put_contents(./cachefile_yuan/pkscc.com/cache/26/44051/9933d.html): failed to open stream: No such file or directory in /www/wwwroot/zhenghe1718.com/func.php on line 115
CTEP,mGlu5Antagonist M60099-5s|产品详情|进口橙子视频旧款采购网




  • 橙子视频app安卓下载,91橙子视频,橙子视频旧款,橙子视频在线官网

    订购信息
    上海橙子视频app安卓下载生物科技公司
    Tel:400-968-7988    021-33779008
    CTEP,mGlu5Antagonist
    品牌:Xcessbio
    货号:M60099-5s
    规格:5 mg solid
    货期:

    CTEP,mGlu5Antagonist

    商品详情 参考文献 相关资料
    Product Information
    Molecular Weight: 391.77
    Formula: C19H13ClF3N3O
    Purity: ≥ 98%
    CAS#: 871362-31-1
    Solubility: DMSO up to 100 mM
    Chemical Name: 2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)ethynyl)pyridine
    Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

    Details

     

    Biological Activity:

    CTEP is a highly potent, selective and orally bioavailable allosteric antagonist of mGlu5 receptor with an IC50 of 2.2 nM. It shows >1000-fold selectivity against 103 targets, including all known mGlu receptors. CTEP can penetrate the brain with a brain/plasma ratio of 2.6.  CTEP is active in the stress-induced hyperthermia procedure in mice and the Vogel conflict drinking test in rats with minimal effective doses of 0.1 and 0.3 mg/kg, respectively, reflecting a 30- to 100-fold higher in vivo potency compared with 2-methyl-6-(phenylethynyl)pyridine (MPEP) and fenobam. CTEP is the first reported mGlu5 inhibitor with both long half-life of approximately 18 h and high oral bioavailability allowing chronic treatment with continuous receptor blockade with one dose every 48 h in ***** and newborn animals. Acute CTEP treatment corrects elevated hippocampal long-term depression, protein synthesis, and audiogenic seizures. Chronic treatment that inhibits mGlu5 within a receptor occupancy range of 81% ± 4% rescues cognitive deficits, auditory hypersensitivity, aberrant dendritic spine density, overactive ERK and mTOR signaling, and partially corrects macroorchidism. By enabling long-term treatment through a wide age range, CTEP allows the exploration of the full therapeutic potential of mGlu5 inhibitors for indications requiring chronic receptor inhibition.

     

    How to Use:

    • In vitro:  CTEP was used at 0.03-0.1 µM final concentration in vitro and in cellular assays.
    • In vivo: CTEP was orally dosed to mice at single 0.1-1.0 mg/kg, or with a dose of 2 mg/kg orally every 48 h for 2 months.  CTEP was orally dose at 2 mg/kg BID achieves uninterrupted mGlu5 occupancy per 48 hours in mice.

     

    Reference:

    • 1. Lindemann L, et al. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor. (2011) J Pharmacol Exp Ther. 339(2):474-86.
    • 2. Michalon A, et al. Chronic pharmacological mGlu5 inhibition corrects fragile X in ***** mice. (2012) Neuron. 74(1):49-56.



    • Product Specification:
    • Product MSDS:




    Products are for research use only. Not for human use.

    • 关于橙子视频app安卓下载
    • 购物流程
    • 支付方式
    • 配送方式
    Copyright@ 2003-2026  进口橙子视频旧款采购网版权所有     

    BIOLEAF热搜   BIOLEAF91橙子视频   BIOLEAF ELISA   BIOLEAF橙子视频旧款   BIOLEAF品牌   BIOLEAF抗体   BIOLEAF耗材   BIOLEAF小仪器

    sitemap   细胞库查询   危险品图标

    本公司网站所展示销售的产品仅供科研!

             沪ICP备08023583号-6     
    产品咨询
    QQ扫码沟通
    在线客服
    服务电话
    400-968-7988
    扫码关注
    微信公众号二维码

    沪公网安备 31011202007338号

    网站地图